1. Sluder JA, Newhouse P, Fain D. Pediatric and adolescent multiple sclerosis. Adolesc Med 2002; 13(3): 461-85.
2. Kasper D, Braunwald E, Fauci A, et al. Harrison's principles of internal medicine. 16th ed. New York: McGraw-Hill Medical Publishing; 2005.
3. Orton SM, Herrera BM, Yee IM, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006; 5(11): 932-6.
4. Nabavi S, Poorfarzam S, Ghassemi H. Clinical course and prognosis of 203 patients with MS in shahid Mustafa Khomeini Hospital, Tehran 2002. Tehran Univ Med J 2006; 64 (7): 90-7.
5. Payamani F, Miri M. Signsand symptoms ofMSin patients withmultiple sclerosis. Mandish 2012; 2 (2-3): 1-6 [Persian].
6. Jalkanen A, Alanen A, Airas L, Group FMSaPS. Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland. Mult Scler 2010; 16(8):950-5.
7. Korn-Lubetzki I, Kahana E, Cooper G, et al. Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol 1984;16(2):229-31.
8. Gold SM, Voskuhl RR. Estrogen and testosterone therapies in multiple sclerosis. Progress in Brain Res 2009; 175: 239-251. doi:10.1016/S0079-6123(09)175167
9. Airas L, Saraste M, Rinta S, et al. Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells. Clin Exp Immunol 2008;151(2):235-43.
10. Braunwald E, Fauci AS, Harrison’s principles of internal medicine, 16th edition, Mc Grow-Hill publ 2005; 2461-2470.
11. Naseri M, Ahmadi A, Gharegezli K, et al. Evaluation of Clinical Toxicology of Naturalproducts M14in patients with MS. Daneshvar 2007; 14(68): 59- 64[(Persian].
12. Fox RJ. Complementary and alternative medicine in multiple sclerosis. J Neurology 2014; 82(12): e 103-7.
13. Seddighi Zh, Mafton F, Moshrafi M. Knowledge and insight to complementary medicine and the rate of the service population of Tehran, monitoring. Payesh 2005; 3(4): 279-89[Persian].
14. Surjushe A, Vasani R, Saple DG. Aloe vera: a short review. Indian J Dermatol 2008; 53(4): 163-6.
15. Mazzanti C, Spanevello R, Morsch A, et al. Previous treatment with ebselen and vitamin E alters adenine nucleotide hydrolysis in platelets from adult rats experimentally demyelinated with ethidium bromide. Life Sci 2007; 81: 241 248.
16. Mosayebi GH, Ghazavi A, Aghili B. Aloe VeraImmunomedulatoryactivityinan animal model ofmultiple sclerosis. J of Arak Univ of Med Sci 2009; 12 (3): 109-115[Persian].
17. Modaresi M,Khodad AR. The Effects of Aloe Vera Extract on Spermatogenesis and Reproductive Hormones in Mice. Res J Biol Sci 2014; 9(5): 165-168.[Persian].
18. Azarnia M, Neyboni M, Rajabi zelati S, et al. The impactof bee venom ondemyelinationin Wistarratsdemyelinationwithethidium bromide. J Biol Iran 2009; 22 (4): 566-573[Persian].
19. Grinsted L, Heltberg A, Hagen C,et al. Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis. J Int Med 1989; 226(4): 241-4.
20. Bansil S, Lee HJ, Jindal S, et al. Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis. Acta Neural Scand 1999; 99(2): 91-4.
21. Offner H. Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalopathies: Therapeutic implications for multiple sclerosis. J Neurosci Res 2004;78(5):603-24.
22. Pourfarid M, Karimijashni HA, Hoshmand F. Effect of Aloe veraplantextractonthe serumlevels of the hormones estrogen and progesterone, and gonadotropinsin rats. J Jahrom Univ of Med Sci 2012; 10 (4): 7-12[Persian].
23. Rengin K, Gullan A. Investigation of the effects of Aloe barbadensis on rat ovaries. J of Med Food 2009; 2(6): 1393-7.
24. Kosif R, Akat G, Oztekin A. Microscopic examination of placenta of rats prenatally exposed to Aloe barbadensis: a preliminary study. Int J Morphol 2008; 26(2): 275-81.